World's Best Scientists 2026 revealed!
Award Badge
Best Scientists
2025
Award Badge
Medicine
Italy
2026

D-Index & Metrics

Best Scientists

D-Index
171
Citations
158597
World Ranking
820
National Ranking
10

Medicine

D-Index
175
Citations
164056
World Ranking
421
National Ranking
7

Aldo P. Maggioni publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Aldo P. Maggioni sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,343 publications — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Aldo P. Maggioni D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Aldo P. Maggioni sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 175 D-Index — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Medicine in Italy Leader Award
  • 2025 - Research.com Best Scientists Award
  • 2025 - Research.com Medicine in Italy Leader Award
  • 2023 - Research.com Medicine in Italy Leader Award

Overview

Aldo P. Maggioni is affiliated with the Heart Care Foundation and the ANMCO Research Center in Florence, Italy. Their research primarily spans the field of Medicine, with a strong focus on Cardiology and Cardiovascular Medicine.

The scientist has contributed extensively to several subfields including Surgery, Economics and Econometrics, Endocrinology, Diabetes and Metabolism, and Epidemiology.

Their work addresses key topics such as Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, Health Systems, Economic Evaluations, Quality of Life, Atrial Fibrillation Management and Outcomes, Cardiac pacing and defibrillation studies, Acute Myocardial Infarction Research, and Diabetes Treatment and Management.

Notable recent papers by Aldo P. Maggioni include:

  • Initial Invasive or Conservative Strategy for Stable Coronary Disease, 2020, New England Journal of Medicine
  • Empagliflozin in Patients with Chronic Kidney Disease, 2022, New England Journal of Medicine
  • European Society of Cardiology: cardiovascular disease statistics 2021, 2021, European Heart Journal
  • Admission of patients with STEMI since the outbreak of the COVID-19 pandemic: a survey by the European Society of Cardiology, 2020, European Heart Journal - Quality of Care and Clinical Outcomes
  • Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT), 2020, European Heart Journal

Aldo P. Maggioni collaborates frequently with several researchers, including Luigi Tavazzi, John J.V. McMurray, Chris P Gale, Cécile Laroche, and Scott D. Solomon.

The researcher often publishes in a variety of venues, with the most frequent among them being:

  • European Heart Journal
  • PubMed
  • European Journal of Heart Failure
  • European Heart Journal - Quality of Care and Clinical Outcomes
  • International Journal of Cardiology

Best Publications

  • ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.

    Stamatis Adamopoulos;Stefan D. Anker;Volkmar Falk;Lars Køber

  • ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

    John J.V. McMurray;Stamatis Adamopoulos;Stefan D. Anker;Angelo Auricchio

  • 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.

    Gilles Montalescot;Udo Sechtem;Stephan Achenbach;Felicita Andreotti

  • Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both

    Marc A. Pfeffer;John J.V. McMurray;Eric J. Velazquez;Jean-Lucien Rouleau

  • Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

    Naveed Sattar;David Preiss;Heather M Murray;Paul Welsh

  • Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.

    Nagesh S Anavekar;John J V McMurray;Eric J Velazquez;Scott D Solomon

  • Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome

    Marc A. Pfeffer;Brian L. Claggett;Rafael Diaz;Kenneth Dickstein

  • ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group.

    R Collins;R Peto;M Flather;S Parish

  • The Seattle Heart Failure Model Prediction of Survival in Heart Failure

    Wayne C. Levy;Dariush Mozaffarian;David T. Linker;Santosh C. Sutradhar

  • Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

    John W. Eikelboom;Stuart J. Connolly;Jackie Bosch;Gilles R. Dagenais

  • Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction

    Jean-Claude Tardif;Simon Kouz;David D. Waters;Olivier F. Bertrand

  • Early Protection Against Sudden Death by n-3 Polyunsaturated Fatty Acids After Myocardial Infarction Time-Course Analysis of the Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione

    Roberto Marchioli;Federica Barzi;Elena Bomba;Carmine Chieffo

  • Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial

    Johannes F. E. Mann;Roland E Schmieder;Matthew McQueen;Leanne Dyal

  • Basal insulin and cardiovascular and other outcomes in dysglycemia

    Origin Trial Investigators;Hertzel C Gerstein;Jackie Bosch;Gilles R Dagenais

  • Initial invasive or conservative strategy for stable coronary disease.

    David J. Maron;Judith S. Hochman;Harmony R. Reynolds;Sripal Bangalore

  • Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.

    Rury R. Holman;M. Angelyn Bethel;Robert J. Mentz;Vivian P. Thompson

  • Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure: The EVEREST Outcome Trial

    Marvin A. Konstam;Mihai Gheorghiade;John C. Burnett;Liliana Grinfeld

  • Angiotensin-Neprilysin inhibition in heart failure with preserved ejection fraction

    Scott D. Solomon;John J.V. McMurray;Inder S. Anand;Junbo Ge

  • Guidelines for the diagnosis and treatment of pulmonary hypertension

    Marius M. Hoeper;Marc Humbert;Adam Torbicki;Jean-Luc Vachiery

  • Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure

    Marvin A. Konstam;Mihai Gheorghiade;John C. Burnett;Liliana Grinfeld

Frequent Co-Authors

Luigi Tavazzi
Luigi Tavazzi University of Ferrara
Roberto Latini
Roberto Latini Mario Negri Institute for Pharmacological Research
Gianni Tognoni
Gianni Tognoni University of Milan
John J.V. McMurray
John J.V. McMurray University of Glasgow
Faiez Zannad
Faiez Zannad University of Lorraine
Scott D. Solomon
Scott D. Solomon Brigham and Women's Hospital
Karl Swedberg
Karl Swedberg University of Gothenburg
Mihai Gheorghiade
Mihai Gheorghiade Northwestern University
Marc A. Pfeffer
Marc A. Pfeffer Harvard Medical School
Lars Køber
Lars Køber Copenhagen University Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring career options in medicine goes beyond becoming a doctor. Today, there are flexible online degrees and career pathways for those interested in healthcare, each offering unique advantages.

For individuals seeking administrative roles, healthcare administration degrees help you advance quickly through accelerated online programs, preparing you for leadership positions in medical settings. If you wish to get started in nursing but want to avoid traditional entrance exams, consider enrolling in a lpn school without teas test requirements for a smoother admission process.

Those interested in coding and office management in healthcare should look into colleges that provide financial aid for medical billing and coding degrees, making these programs more accessible. Additionally, registered nurses with an associate degree can accelerate their careers through asn to np programs, bridging to nurse practitioner roles in less time.

These diverse pathways open doors to rewarding healthcare careers without following the traditional medical school route.

Best Scientists Citing Aldo P. Maggioni

Trending Scientists

Recently Published Articles